Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
04/1998
04/21/1998US5741892 Pentapeptides as antitumor agents
04/21/1998US5741891 Pulmonary surfactant peptide solubilization process
04/21/1998US5741815 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor
04/21/1998US5741809 Compounds and methods for the treatment of cardiovascular inflammatory and immune disorders
04/21/1998US5741797 Heteroatom substituted alkyl benzylaminoquinuclidines
04/21/1998US5741790 Tachykinin antagonist and intermediates for nervous system disorders, antiinflammatory agents, antiarthritic agents, antidepressants and gastrointestinal disorders
04/21/1998US5740793 Dry powder inhalation device with elongate carrier for power
04/16/1998WO1998015624A1 Galectin 8, 9, 10 and 10sv
04/16/1998WO1998015575A1 Promoter for smooth muscle cell expression
04/16/1998WO1998015282A1 Immunogenic tlp composition
04/16/1998WO1998015280A1 New combination
04/16/1998WO1998009970A3 Alkylated rapamycin derivatives
04/16/1998CA2268022A1 Galectin 8, 9, 10 and 10sv
04/16/1998CA2267905A1 Immunogenic tlp composition
04/16/1998CA2267067A1 Promoter for smooth muscle cell expression
04/16/1998CA2239308A1 New combination
04/15/1998EP0835936A2 Arginyl tRNA synthase
04/15/1998EP0835313A1 Omp26 antigen from haemophilus influenzae
04/15/1998EP0835128A1 Use of il-11 to treat inflammation
04/14/1998US5739351 Neurokinin a antagonists
04/14/1998US5739300 Antiadhesive piperidine-and pyrrolidinecarboxylic acids
04/14/1998US5739157 Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase
04/14/1998US5739149 Treating asthma
04/14/1998US5739148 6-(2-Imidazolinylamino) quinoline compounds useful as alpha-2 adrenoceptor agonists
04/14/1998US5739144 Trisubstituted phenyl derivatives
04/14/1998US5739138 Modulators of cellular response
04/14/1998US5739103 Mutants; antiinflammatory agents; anticholesterol agents; cardiovascular disorders; antiarthritic agents
04/14/1998US5738872 Antiallergens, antihistamines; bioavailability
04/09/1998WO1998014596A2 Disease associated protein tyrosine phosphatases
04/09/1998WO1998014480A1 G protein-coupled receptor antagonists
04/09/1998WO1998014432A1 Pde iv inhibiting 2-cyanoiminoimidazole derivatives
04/09/1998WO1998014210A1 Method for treating allergic lung disease
04/09/1998CA2267675A1 Method for treating allergic lung disease
04/09/1998CA2267190A1 G protein-coupled receptor antagonists
04/09/1998CA2265449A1 Disease associated protein tyrosine phosphatases
04/08/1998EP0834565A2 A G-protein coupled receptor HUVCT36
04/08/1998EP0834510A2 Flavone derivative and medicine comprising the same
04/08/1998EP0834508A1 Substituted biphenyl or phenylpyridine derivatives, process for their preparation and pharmaceutical compositions containing them
04/08/1998EP0833828A1 Rapamycin derivatives
04/08/1998EP0833664A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b 4? receptor antagonist for the treatment of inflammations
04/08/1998EP0833650A1 P-selectin ligands and related molecules and methods
04/08/1998EP0833622A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
04/08/1998EP0680488B1 2,6-diaminopurine derivatives
04/08/1998CN1178532A Tricyclic vasopressin antagonists
04/08/1998CN1178529A Heterocyclic subsitituted piperazinone derivatives as tachykinin receptor antagonists
04/07/1998US5736535 1-pyrimidinylacetamide compounds which are inhibitors of human leukocyte elastase
04/07/1998US5736533 Inhibiting colonization of streptococcus pneumoniae, hemophilus influenza or parainfluenza, burkholderia (pseudomonas) cepacia by administering binding inhibiting oligosaccharide
04/07/1998US5736381 An isolated and purified polynucleotide sequence encoding a polypeptide containing specific amino acid sequence
04/07/1998US5736143 Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides
04/07/1998CA2146259C Substituted benzylaminoquinuclidines
04/07/1998CA2084193C 3-amino-2-aryl quinuclidines
04/07/1998CA2003441C Quinuclidine therapeutic agents
04/07/1998CA1339802C Diarylstrylquinoline diacids
04/02/1998WO1998013369A1 Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists
04/02/1998WO1998013366A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
04/02/1998WO1998013058A1 Methods for treating an ischemic disorder and improving stroke outcome
04/02/1998WO1998013031A2 Medicinal aerosol formulations comprising budesonide
04/02/1998WO1998013029A1 Oral delayed immediate release formulation and method of preparation therefor
04/02/1998CA2266431A1 Medicinal aerosol formulations comprising budesonide
04/02/1998CA2265950A1 Spiro-azacyclic derivatives and their use as therapeutic agents
04/01/1998EP0832886A1 Flavon derivatives, process for their preparation, and pharmaceutical compositions containing them
04/01/1998EP0832272A1 Cationic lipid:dna complexes for gene targeting
04/01/1998EP0832253A2 Nucleic acid respiratory syncytial virus vaccines
04/01/1998EP0832217A1 Modified steroid hormones for gene therapy and methods for their use
04/01/1998EP0832082A1 N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists
04/01/1998EP0832076A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
04/01/1998EP0832071A1 1,3-dihydro-2h-imidazol-2-one derivatives having pde iv and cytokinin inhibiting activity
04/01/1998EP0831924A1 Method of treatment for asthma
04/01/1998EP0831903A1 Connective tissue growth factor
04/01/1998EP0831893A1 Regulation of cytokine synthesis and release
04/01/1998EP0831885A1 Methods and uses of connective tissue growth factor as an induction agent
04/01/1998EP0831875A1 Methods of inhibiting phagocytosis
04/01/1998EP0831848A1 Method of treatment for lung diseases using antisense oligonucleotides
04/01/1998EP0831830A1 Imidazole compounds
04/01/1998EP0831823A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
04/01/1998EP0831817A1 Antigen-processing cell-targeted conjugates
04/01/1998EP0831813A1 Methods of inhibiting pneumocystis carinii pneumonia and compounds useful therefor
04/01/1998EP0831811A1 Methods of treating microbial infections
04/01/1998EP0831777A1 Dinucleotides useful for the treatment of lung disease
04/01/1998EP0741707B1 SUBSTITUTED AROMATIC COMPOUNDS AS c.AMP PHOSPHODIESTERASE- AND TNF-INHIBITORS
03/1998
03/31/1998US5734051 8-substituted xanthine derivatives and method of use thereof
03/31/1998US5733939 Fluorocarbons as anti-inflammatory agents
03/31/1998US5733923 Secretory pancreatic phospholipase a2
03/31/1998US5733901 Administering to treat skin and respiratory system disorders, inflammatory disorders of the bowel, and allergic rhinitis/conjunctivitis
03/31/1998CA2116356C Antimuscarinic bronchodilators
03/26/1998WO1998012334A2 Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin
03/26/1998WO1998012329A2 Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin
03/26/1998WO1998012211A1 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
03/26/1998WO1998012210A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators
03/26/1998WO1998012176A1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators
03/26/1998WO1998011915A1 Strain selection of pneumococcal surface proteins
03/26/1998WO1998011901A1 Inositol polyphosphate derivatives and methods of using same
03/26/1998CA2267348A1 Inositol polyphosphate derivatives and methods of using same
03/26/1998CA2267343A1 Strain selection of pneumococcal surface proteins
03/26/1998CA2266849A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators
03/26/1998CA2266639A1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators
03/26/1998CA2266341A1 Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin
03/26/1998CA2266339A1 Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin
03/25/1998EP0831090A1 N-substituted cyclic amines, process for their preparation and pharmaceutical compositions containing them
03/25/1998EP0830374A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
1 ... 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 ... 878